1.Company Information

Dr. Agarwal's Health Care Limited is a comprehensive eye care services provider with a network of 209 facilities as of September 30, 2024. The company offers a range of services including:
1) Cataract, refractive, and other surgeries
2) Consultations, diagnoses, and non-surgical treatments
3) Sale of opticals, contact lenses, accessories, and eye care-related pharmaceutical products
The company aims to address all patient needs throughout their eye treatment journey.
Manufacturing Facility:
The company has a subsidiary, Elisar Life Sciences Private Limited (ELSPL), engaged in the development, design, manufacturing, importing, and exporting of high-quality healthcare devices, including ophthalmic diagnostic devices.
Key Geographies:
The company operates in India and also has international operations. In India, the company has a diversified presence across Tier-I cities and other cities. The company's international operations span across nine countries in Africa. The company tracks revenue from operations in India and outside of India to monitor their performance in different markets.

2. Strengths

1) Largest Eye Care Services Provider in India with a Trusted Brand
2) End-to-End, Comprehensive Eye Care Services Offering
3) Scalable, Asset-Light, Hub-and-Spoke Operating Model
4) Doctor-Promoters Leading a Team of Qualified Medical Professionals
5) Proven Track Record of Growth and Scalability

3. Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:
1) Repayment/prepayment, in part or full, of certain of the borrowings and
2) General corporate purposes and unidentified inorganic acquisition.

4.Dr. Agarwal's Health Care Limited IPO Registrar

Kfin Technologies Limited

Phone: 04067162222, 04079611000

Email: ahcl.ipo@kfintech.com

Website: https://kosmic.kfintech.com/ipostatus/